Datasea (Nasdaq:DTSS) announced progress on R&D efforts related to its brain-computer interface (BCI) technologies.

Salmon retired from Medtronic in September after a more than 20-year tenure at the medtech giant. Most recently, Salmon ...

ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...

Johnson & Johnson MedTech will be one of several companies set to benefit from a new CMS decision related to pulsed field ...

Weispfenning has more than 25 years of experience at Medtronic, joining its IR team 17 years ago. He led the function at the ...

Intuitive announced that the FDA cleared its da Vinci single port (SP) surgical robot for use in new types of procedures.

Flow Neuroscience announced that the FDA approved its Flow at-home brain stimulation device for treating major depressive ...

Boston Scientific announced today that Health Care Service Corporation (HCSC) now covers its Intracept procedure.

Neurovalens announced that it received FDA de novo approval for Modius Lean, its non-invasive neurotechnology for weight ...

Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Impulse Dynamics announced today that it raised more than $158 million in financing to support its heart failure treatment ...

Brain-computer interface (BCI) company Science Corp. announced that it appointed Darius Shahida as its new chief strategy ...